| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |